Time for a neurorestorative therapy in stroke

Bibliography

• Sivenius J, Tuomilehto J, Immonen-Raiha P, Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke 2004;35:420-5
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Collins R, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;30:1849-60
   Google Scholar
• Diener HC, Cunha L, Forbes C; European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13
   PubMed Web of Science ®Google Scholar
• Diener HC, Sacco RL, Yusuf S, Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008;7:875-84
   PubMed Web of Science ®Google Scholar
• Bousser MG, Amarenco P, Chamorro A, Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet 2011;377:2013-22
   PubMed Web of Science ®Google Scholar
• Diener HC, Connolly SJ, Ezekowitz MD, Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol 2010;9:1157-63
   PubMed Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J, Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91
   PubMed Web of Science ®Google Scholar
• Granger CB, Alexander JH, McMurray JJ, Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92
   PubMed Web of Science ®Google Scholar
• Lees KR, Bluhmki E, von Kummer R, Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;3751:695-703
   Google Scholar
• Amaro S, Chamorro A. Translational stroke research of the combination of thrombolysis and antioxidant therapy. Stroke 2011;42:1495-9
   PubMed Web of Science ®Google Scholar
• Jahan R, Vinuela F. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Expert Rev Cardiovasc Ther 2009;7:375-87
   PubMedGoogle Scholar
• O'Collins VE, Macleod MR, Donnan GA, 1,026 experimental treatments in acute stroke. Ann Neurol 2006;59:467-77
   PubMed Web of Science ®Google Scholar
• Sahota P, Savitz S. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics 2011;8:434-51
   PubMed Web of Science ®Google Scholar
• Ginsberg MD, Palesch YY, Martin RH, The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke 2011;42:119-27
   PubMed Web of Science ®Google Scholar
• Available from: www.clinicaltrials.com
   Google Scholar
• Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009;8:491-500
   PubMed Web of Science ®Google Scholar
• Font MA, Arboix A, Krupinski J. Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev 2010;6:238-44
   PubMedGoogle Scholar
• Chollet F, Tardy J, Albucher JF, Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011;10:123-30
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Bogousslavsky J. Trafermin for stroke recovery: is it time for another randomized clinical trial? Expert Opin Biol Ther 2011;11:1533-41
   PubMed Web of Science ®Google Scholar
• Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE; Citicoline Stroke Study Group. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 2001;57:1595-602
   PubMed Web of Science ®Google Scholar
• Bogousslavsky J, Victor SJ, Salinas EO, Fiblast (trafermin) in acute stroke: results of the European-Australian Phase II/III safety and efficacy trial. Cerebrovasc Dis 2002;14:239-51
   PubMed Web of Science ®Google Scholar
• Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drugs. Stroke 1999;30:2752-8
   PubMed Web of Science ®Google Scholar
• Chen HH, Chien CH, Liu HM. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 1994;25:1651-7
   PubMed Web of Science ®Google Scholar
• Kawamata T, Alexis NE, Dietrich WD, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 1996;16:542-7
   PubMed Web of Science ®Google Scholar
• Kawamata T, Dietrich WD, Schallert T, Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci USA 1997;94:8179-84
   PubMed Web of Science ®Google Scholar
• Won SJ, Xie L, Kim SH, Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res 2006;1123:237-44
   PubMed Web of Science ®Google Scholar
• Wang ZL, Cheng SM, Ma MM, Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia. Neurosci Lett 2008;446:30-5
   PubMed Web of Science ®Google Scholar
• Matsuse D, Kitada M, Ogura F, Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats. Tissue Eng Part A 2011;17:1993-2004
   PubMed Web of Science ®Google Scholar
• Levin MF, Kleim JA, Wolf SL. What do motor "recovery" and "compensation" mean in patients following stroke? Neurorehabil Neural Repair 2009;23:313-19
   PubMed Web of Science ®Google Scholar